It is based on the scientific understanding and high - throughput analyses
of human immune responses to disease - related proteins in selected populations including elderly with the capability to stay healthy during the aging process.
Such models are valuable for the analysis of parameters associated with vaccine safety, immunogenicity, delivery and protection as NHPs replicate key features
of the human immune response more faithfully than any other animal model.
Not exact matches
The advance, reported in Proceedings
of the National Academy
of Sciences (PNAS) journal, for the first time allows scientists to analyze how normal gut microbes and pathogenic bacteria contribute to
immune responses, and to investigate IBD mechanisms in a controlled model that recapitulates
human intestinal physiology.
Another important feature
of this antibody is that it acts on a part
of the virus that is not normally targeted by the normal
human immune response.
Already the advance has revealed new discoveries into the inner workings
of the
human intestinal tract and its
immune responses.
In the meantime, for
humans more than 1,200 different short, single - stranded RNA molecules have been named, some
of them playing an important role in
immune response.
With our
human gut - on - a-chip, we can not only culture the normal gut microbiome for extended times, but we can also analyze contributions
of pathogens,
immune cells, and vascular and lymphatic endothelium, as well as model specific diseases to understand complex pathophysiological
responses of the intestinal tract.»
A 2 - year fellowship from the
Human Science Frontier Program financed a postdoc at Yale University School
of Medicine on the role
of so - called «toll - like receptors» in
immune responses.
Nibbering and a team
of Dutch collaborators are trying to combat these biofilm - associated infections by improving on a
human peptide called LL - 37, which helps regulate the body's
immune response.
However, some mice experienced dangerous levels
of brain swelling, a side effect
of the
immune response triggered by the engineered cells, the researchers said, adding that extreme caution will be needed to introduce the approach in
human clinical trials.
Using cells from cadavers, doctors have been experimentally transplanting pancreatic islets into
humans for decades, but as many as 60 percent
of the transplanted islets die immediately because they are cut off from their blood supply and are killed by an
immune response due to direct injection into the bloodstream, and those that survive the transplant usually die within several months.
«Much further work in both models and
humans is required to fully untangle this complex web
of immune responses.
The authors said that this result suggests that the reason bacterial numbers are so high in these mice, and, by extension,
human LAD patients, is not because
of a defect in the
immune system's surveillance mechanism but because
of the inflammation caused by the
immune system's abnormal
response to normal levels
of bacteria in the gums.
Dupilumab, a fully
human monoclonal antibody discovered by Regeneron Pharmaceuticals and being developed by Regeneron and Sanofi, thwarts activation
of the Th2
immune response implicated in asthma by blocking two cytokines, interleukin - 4 and interleukin - 13.
Two new studies reveal that administering a potent, broadly neutralizing antibody that binds to HIV evokes a strong
immune response in
humans, and can even accelerate the clearance
of infected cells.
«The imaging technique could shed light on the
immune dysfunction that underpins a broad range
of neuroinflammatory diseases, such as Alzheimer's disease, depression, post-traumatic stress disorder and addiction,» said Christine Sandiego, PhD, lead author
of the study and a researcher from the department
of psychiatry at the Yale School
of Medicine in New Haven, Conn. «This is the first
human study that accurately measures this
immune response in the brain.
«Our findings show that population differences in transcriptional
responses to
immune activation are widespread, and that they are mainly accounted for by genetic variants that differ in their frequencies between
human populations,» said Lluis Quintana - Murci
of Institut Pasteur and CNRS in Paris, France, who led one
of the two studies.
The paper focuses on two key molecular players in the story
of influenza infection: a
human protein called TRIM25, which was recently discovered to play an important role in the
human immune response to flu infection; and a protein called NS1 present in all strains
of the influenza A virus and shown to bind TRIM25 to keep it from doing its job.
A
human enzyme that can degrade the chitin
of insect exoskeletons also regulates allergic inflammation in asthma, reinforcing the similarities between
immune responses to parasitic and allergic stimuli.
While the inflammatory
immune response is essential to protecting
humans against viruses and bacteria, superantigen toxins cause an exaggerated
response called an «
immune storm» that can do a great deal
of damage in the body and can result in multiple organ failure.
«The strategy
of using peptides that mimic regions
of a
human immune receptor, to put the brakes on the excessive inflammatory
response triggered by superantigen toxins, is a host - oriented strategy that is broadly effective against the diverse family
of superantigens,» said Prof. Raymond Kaempfer.
This differential
response depends on a «natural»
immune response environment, that is, on the presence
of human blood serum.
This
response was blocked by a drug that inhibits the complement system, a part
of the non-specific
immune system present in
human blood.
In its first test in
humans, reported online October 4 in the New England Journal
of Medicine, one vaccine based on DNA from the virus elicited an
immune response, with 100 percent
of participants developing antibodies after a three - dose regimen.
Plant
immune systems, like those
of humans and animals, face a difficult balancing act: they must mount
responses against ever - evolving pathogens, but they must not overdo it.
The UNC research team, led by Lemon and Jason Whitmire, Ph.D., Associate Professor in UNC's Department
of Genetics, is now poised to investigate the complicated interplay
of nonspecific «innate» and specific «adaptive»
immune responses that ultimately control the infection and eliminate HAV from the host — processes that are not well understood for any
of the five
human hepatitis viruses.
To develop an effective vaccine, it is imperative to identify a suitable antigen structure
of the virus which will create an effective
immune response in
humans.
With the completion
of the first phase
of the
Human Genome Project in 2000, and the advent
of sequencing technologies that can detect gene variations such as single nucleotide polymorphisms (SNPs), for the first time scientists have the tools in hand to find the key
immune genes and genetic networks that play roles in vaccine
response.
The company now has an array
of fully
human antibodies in its pipeline created with its proprietary VelocImmune mouse, which has been engineered to express
human antibody genes while still mounting a robust
immune response by making antibodies with fully
human variable regions and mouse constant regions.
«Additionally, the development
of immune response against WNV may have reduced
human cases by depleting the susceptible
human population.
Dr. Gnjatic's research focuses on
human antigen - specific
immune responses to tumor antigens, in an attempt to define new targets for the development
of cancer immunotherapies, assess the efficacy
of these immunotherapies, and learn why they may fail.
In a paper published in the journal Proceedings
of the National Academy
of Sciences, Sangeeta Bhatia
of MIT and Charles Rice
of Rockefeller University describe using microfabricated cell cultures to sustain hepatitis B virus in
human liver cells, allowing them to study
immune responses and drug treatments.
«Inappropriate
immune response to commensal bacteria and subsequent pathologic inflammation is a contributing factor to the pathogenesis and progression
of many chronic
human diseases, including inflammatory bowel disease, HIV / AIDS, viral hepatitis, cancer, cardiovascular disease, and diabetes,» says Sonnenberg.
After a flood
of optimism and investment in the early 1990's, the struggle to overcome host
immune response and fears that organs could transmit pig viruses to
humans scared off pharmaceutical funders.
A possible problem facing a
human vaccine is that some people already have an
immune response to some strains
of adenoviruses, which would reduce the body's
response to the vaccine strain.
«Team studies
immune response of Asian elephants infected with a
human disease.»
Looking across evolutionary time and the genomic landscapes
of humans and mice, an international group
of researchers has found powerful clues to why certain processes and systems in the mouse — such as the
immune system, metabolism and stress
response — are so different from those in people.
«The
immune responses are there, the tough call is whether they're enough to protect
humans against Ebola, and I guess we'll find that out in the phase 3 trial,» says Adrian Hill, director
of the Jenner Institute in Oxford, UK, who is leading a small safety trial
of the monovalent NIAID / GSK vaccine.
The HLA (
human leukocyte antigen) is a system
of genes responsible for regulating
immune responses, and peptides are short chains
of amino acids that play key roles in regulating the activities
of other molecules.
For example, investigators found that for the mouse
immune system, metabolic processes and stress
response, the activity
of some genes varied between mice and
humans, which echoes earlier research.
The researchers found that resistin, an
immune protein commonly found in
human serum, instigates an inappropriate inflammatory
response to worm infections, impairing the clearance
of the worm.
These types
of engineered tumors are much more difficult to treat than
human tumors implanted in mice, because they suppress the
immune response against them.
The main change, a point mutation in the
human gene for hu14.18, was designed to address treatment - limiting pain by generating a more tailored
response that avoided triggering part
of the
immune response called the complement cascade.
By analyzing a dataset
of human immune cells stimulated with interferon — a signaling protein created in
response to pathogens or tumor cells — the team could precisely identify which genes were switched on in each
of 13 responding cell types.
IDMIT will contribute 1) To the development and validation
of assays based on flow cytometry and mass cytometry for the evaluation
of immune responses in
humans and animal models; these tools will be particularly relevant for the identification
of signatures
of vaccine efficacy; 2) To the animal model platform, in particularly by providing access to NHP models and to new technologies for in vivo imaging infections and host
responses; 3) To networking activities, in particular by organising a workshop on in vivo imaging.
(PMID: 11279501)[ii] Stamper CC, Zhang Y, Tobin JF, Erbe DV, Ikemizu S, Davis SJ, Stahl ML, Seehra J, Somers WS, Mosyak L. Crystal structure
of the B7 - 1 / CTLA - 4 complex that inhibits
human immune responses.
The scientists who posted this paper argued that a lot
of people had
immune responses to Cas9, because they knew that the two most widely used Cas9 enzymes come from S. aureus and S. pyogenes bacteria, and
humans have been infected by these bacterias for a long time.
Michael Pfreundschuh and colleagues Ugur Sahin and Ozlem Türeci at the University
of Saarland develop SEREX (SErological analysis
of Recombinant cDNA Expression), providing a powerful method to analyze the humoral
immune response to intracellular cancer antigens and ushering in the third phase
of cancer serology, bringing with it the prospect
of providing a comprehensive view
of the
immune recognition
of human cancer.
Hypothesis driven approaches to vaccinology can utilise the knowledge gained from mechanistic mouse models and our molecular understanding
of intrinsic defects to
human cells.5 However, caution is required when extrapolating data from murine models, as there are substantial differences between
immune ageing in mice and
humans.6 Nevertheless, model systems and ex vivo analyses
of molecular alterations in aged
human cells have identified multiple changes in the vaccination
response with age and the aged
immune system in general.
Dr. Anuja Mathew is the newest members
of the iCubed team, joining the Institute in August 2015 to research
human immune responses to dengue virus infections alongside world renowned Dr. Alan Rothman.